<div id="readability-page-1"><p>Praxis Investment Management Inc. grew its stake in shares of  The Campbell's Company (NASDAQ:CPB - Free Report) by 123.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund owned 15,000 shares of the company's stock after purchasing an additional 8,280 shares during the period. Praxis Investment Management Inc.'s holdings in Campbell's were worth $460,000 as of its most recent SEC filing.</p><ul><li>Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look</li></ul><p>Other hedge funds have also modified their holdings of the company. Ameritas Advisory Services LLC purchased a new stake in shares of  Campbell's during the second quarter valued at $25,000.  Manchester Capital Management LLC lifted its holdings in shares of  Campbell's by 923.2% during the first quarter. Manchester Capital Management LLC now owns 706 shares of the company's stock valued at $28,000 after purchasing an additional 637 shares during the last quarter.  ORG Partners LLC lifted its holdings in shares of  Campbell's by 77.3% during the second quarter. ORG Partners LLC now owns 906 shares of the company's stock valued at $29,000 after purchasing an additional 395 shares during the last quarter.  Geneos Wealth Management Inc. lifted its holdings in shares of  Campbell's by 333.3% during the first quarter. Geneos Wealth Management Inc. now owns 975 shares of the company's stock valued at $39,000 after purchasing an additional 750 shares during the last quarter.  Finally, Banque Cantonale Vaudoise purchased a new stake in  Campbell's in the 1st quarter worth about $47,000. 52.35% of the stock is owned by hedge funds and other institutional investors. </p><h2>Campbell's Price Performance</h2><p>Shares of CPB opened at $30.86 on Friday. The firm has a market cap of $9.19 billion, a PE ratio of 15.43, a PEG ratio of 10.72 and a beta of 0.02. The firm's 50 day moving average price is $32.23 and its 200 day moving average price is $33.42. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.28 and a current ratio of 0.77. The Campbell's Company has a twelve month low of $29.39 and a twelve month high of $48.68. </p><ul><li>3 Stocks Presenting Generational Buying Opportunities</li></ul><p>Campbell's (NASDAQ:CPB - Get Free Report) last issued its quarterly earnings data on Wednesday, September 3rd. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.05. The firm had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.33 billion. Campbell's had a net margin of 5.87% and a return on equity of 22.95%. The company's revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.08 earnings per share.  Campbell's has set its FY 2026 guidance at 2.400-2.550 EPS. As a group, research analysts expect that  The Campbell's Company will post 3.15 EPS for the current fiscal year. </p><h2>Campbell's Dividend Announcement</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 2nd will be issued a dividend of $0.39 per share. The ex-dividend date of this dividend is Thursday, October 2nd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 5.1%. Campbell's's dividend payout ratio  is currently 78.00%. </p><h2>Wall Street Analyst Weigh In</h2><ul><li>4 Reasons Campbell’s Stock Could Serve Up Big Returns in 2025</li></ul><p>Several equities research analysts recently issued reports on the company. Wells Fargo &amp; Company increased their price objective on Campbell's from $32.00 to $34.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Thursday, September 25th. Stifel Nicolaus reduced their price objective on Campbell's from $38.00 to $34.00 and set a &#34;hold&#34; rating for the company in a research note on Tuesday, July 29th. TD Cowen increased their price objective on Campbell's from $29.00 to $31.00 and gave the stock a &#34;hold&#34; rating in a research note on Thursday, September 4th. JPMorgan Chase &amp; Co. assumed coverage on Campbell's in a research note on Wednesday, August 20th. They issued a &#34;neutral&#34; rating and a $33.00 price objective for the company. Finally, Morgan Stanley increased their price objective on Campbell's from $32.00 to $33.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating, fifteen have assigned  a Hold rating and five have assigned  a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Reduce&#34; and a consensus target price of $34.82.</p><p><b>Check Out Our Latest Research Report on Campbell's</b></p><h2>Campbell's Profile</h2> (Free Report)<p>The Campbell's Company, formerly known as Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. The company operates through Meals &amp; Beverages and Snacks segments. The Meals &amp; Beverages segment engages in the retail and foodservice businesses in the United States and Canada.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Campbell's</li><li>What is a buyback in stocks? A comprehensive guide for investors</li><li>Johnson &amp; Johnson's M&amp;A Strategy Is the Real Story for Investors</li><li>What is diluted earnings per share (Diluted EPS)?</li><li>Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?</li><li>Retail Stocks Investing, Explained</li><li>Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Campbell's Right Now?</h2><p>Before you consider Campbell's, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.</p><p>While Campbell's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Praxis Investment Management Inc. increased its stake in The Campbell's Company (NASDAQ:CPB) by 123.2% in Q2, owning 15,000 shares valued at $460,000. Other hedge funds also adjusted their holdings. Campbell's reported Q3 earnings of $0.62 per share, beating estimates, with revenue of $2.32 billion. The company announced a quarterly dividend of $0.39 per share, yielding 5.1%. Analysts have mixed ratings on the stock, with price targets ranging from $29 to $38.</p>

The Campbell's Company $CPB Holdings Raised by Praxis Investment Management Inc.